Efficacy of etoposide, cyclophosphamide, and total body irradiation in allogeneic bone marrow transplantation for adult patients with hematological malignancies

Clinical Transplantation

Volumn 18, Issue 5, 2004, Pages 552-557

  Toubai, Tomomi ^a   Tanaka, Junji ^a   Mori, Akio ^a   Hashino, Satoshi ^a   Kobayashi, Sumiko ^a   Ota, Shuichi ^a   Miura, Yoko ^a   Kato, Naoko ^a   Kahata, Kaoru ^a   Izumiyama, Ko ^a   Yonezumi, Masakatu ^a   Chiba, Koji ^a   Kondo, Takeshi ^a   Toyoshima, Nobuyasu ^a   Asaka, Masahiro ^a   Imamura, Masahiro ^a  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Allogeneic bone marrow transplantation; Cyclophosphamide; Etoposide (VP 16); Hematological malignancies; Preconditioning regimen; Total body irradiation

Indexed keywords

CYCLOPHOSPHAMIDE; CYCLOSPORIN A; ETOPOSIDE; METHOTREXATE; TACROLIMUS;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; CANCER PATIENT; CANCER RECURRENCE; CANCER REGRESSION; CANCER SURVIVAL; CAUSE OF DEATH; CLINICAL ARTICLE; CONTROLLED STUDY; DONOR; DRUG EFFICACY; DRUG SAFETY; FEMALE; FOLLOW UP; HEMATOLOGIC MALIGNANCY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MALE; PRIORITY JOURNAL; RELATIVE; STATISTICAL ANALYSIS; SURVIVAL RATE; WHOLE BODY RADIATION;

ADOLESCENT; ADULT; ANTINEOPLASTIC AGENTS, PHYTOGENIC; BONE MARROW TRANSPLANTATION; CAUSE OF DEATH; CYCLOPHOSPHAMIDE; DISEASE-FREE SURVIVAL; ETOPOSIDE; FEMALE; FOLLOW-UP STUDIES; GRAFT SURVIVAL; GRAFT VS HOST DISEASE; HEMATOLOGIC NEOPLASMS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; REMISSION INDUCTION; RETROSPECTIVE STUDIES; SAFETY; SURVIVAL RATE; TRANSPLANTATION CONDITIONING; TREATMENT OUTCOME; WHOLE-BODY IRRADIATION;

EID: 4644242772     PISSN: 09020063     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-0012.2004.00225.x     Document Type: Article

References (22)

1. Brochstein JA, Kernan NA, Groshen S et al. Allogeneic bone marrow transplantation after hyperfractionated total-body-irradiation and cyclophosphamide in children with acute leukemia. N Engl J Med 1987: 317: 1618.
2. Appelbaum FR, Barrall J, Storb R et al. Bone marrow transplantation for patients with myelodysplasia. Ann Int Med 1990: 112: 590.
3. Santos GW, Tutschka PJ, Brookmeyer R et al. Marrow transplantation for acute non lymphocytic leukemia after treatment with busulfan and cyclophosphamide. N Engl J Med 1983: 309: 1347.
4. Coccia PF, Strandjord SE, Warkentin PI et al. Highdose cytosine arabinoside and fractionated total-body irradiation: an improved preparative regimen for bone marrow transplantation of children with acute lymphoblastic leukemia in remission. Blood 1988: 71: 888.
5. Schmitz N, Gassmann W, Rister M et al. Fractionated total body irradiation and high-dose VP-16-213 followed by allogeneic bone marrow transplantation in advanced leukemias. Blood 1988: 72: 1567.
6. Spitzer TR, Cottler-Fox M, Torrisi J et al. Escalating doses of etoposide with cyclophosphamide and fractionated total body irradiation or busulfan as conditioning for bone marrow transplantation. Bone Marrow Transplant 1989: 4: 559.
7. Bostrom B, Weisdorf DJ, Kim T, Kersey JH, Ramsay NKC. Bone marrow transplantation for advanced acute leukemia: a pilot study of high-energy total body irradiation, cyclophosphamide and continuous infusion etoposide. Bone Marrow Transplant 1990: 5: 83.
8. Yau JC, LeMaistre CF, Andersson BS et al. Allogeneic bone marrow transplantation for hematological malignancies following etoposide, cyclophosphamide, and fractionated total body irradiation. Am J Hematol 1992: 41: 40.
9. Petersen FB, Buckner CD, Appelbaum FR et al. Etoposide, cyclophosphamide and fractionated total body irradiation as a preparative regimen for marrow transplantation in patients with advanced hematological malignancies: a phase 1 study. Bone Marrow Transplant 1992: 10: 83.
10. Spiter TR, Peters C, Ortlieb M et al. Etoposide in combination with cyclophosphamide and total body irradiation or busulfan as conditioning for marrow transplantation in adults and children. Int J Radiat Oncol Biol Phys 1994: 29: 39.
11. Giralt SA, LeMaistre CF, Vriesendorp HM et al. Etoposide, cyclophosphamide, total-body irradiation, and allogeneic bone marrow transplantation for hematologic malignancies. J Clin Oncol 1994: 12: 1923.
12. Brown RA, Wolff SN, Fay JW et al. High-dose etoposide, cyclophosphamide, and total body irradiation with allogeneic bone marrow transplantation for patients with acute myeloid leukemia in untreated first relapse: a study by the North American Marrow Transplant Group. Blood 1995: 85: 1391.
13. Brown RA, Wolff SN, Fay JW et al. High-dose etoposide, cyclophosphamide and total body irradiation with allogeneic bone marrow transplantation for resistant acute myeloid leukemia: a study by the North American Marrow Transplant Group. Leuk lymphoma 1996: 22: 271.
14. Long GD, Amylon MD, Stockerl-Goldstein KE et al. Fractionated total-body irradiation, etoposide, and cyclophosphamide followed by allogeneic bone marrow transplantation for patients with high-risk or advanced-stage hematological malignancies. Biol Blood Marrow Transplant 1997: 3: 324.
15. Duerst RE, Horan JT, Liesveld JL et al. Allogeneic bone marrow transplantation for children with acute leukemia: cytoreduction with fractionated total body irradiation, high-dose etoposide and cyclophosphamide. Bone Marrow Transplant 2000: 25: 489.
16. Glucksberg H, Storb R, Fefer A et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HLA-matched sibling donors. Transplantation 1974; 18: 295.
17. Shulman HM, Sullivan KM, Weiden PL et al. Chronic graft-versus-host disease in man. A long-term clinicopathologic study of 20 Seattle patients. Am J Med 1980: 69: 204.
18. Szydlo R, Goldman JM, Klein JP et al. Results of allogeneic bone marrow transplants for leukemia using donors other than HLA-identical siblings. J Clin Oncol 1997: 15: 1767.
19. Chang TT, Gulati SC, Chou TC et al. Synergistic effect of 4-hydroperoxycyclophosphamide and etoposide on a human promyelocytic leukemia cell line (HL-60) demonstrated by computer analysis. Cancer Res 1985: 45: 2434.
20. Blume KG, Kopecky KJ, Henslee-Downey JP et al. A prospective randomized comparison of total body irradiation-etoposide versus busulfan-cyclophosphamide as preparatory regimens for bone marrow transplantation in patients with leukemia who were not in first remission: a Southwest Oncology Group study. Blood 1993: 81: 2187.
21. Parsons SK, Castellino SM, Lehmann LE et al. Relapsed acute lymphoblastic leukemia: similar outcomes for autologous and allogeneic marrow transplantation in selected children. Bone Marrow Transplant 1996: 17: 763.
22. Imamura M, Hashino S, Kobayashi S et al. Hyperacute graft-versus-host disease accompanied by increased serum interleukin-6 levels. Int J Hematol 1994: 60: 85.